Haemophilia prophylactic treatment in Spain

被引：4
|
作者：
Tusell, J [1 ]
Cid, AR [1 ]
Sosa, R [1 ]
Villar, A [1 ]
Lucia, JF [1 ]
机构：
[1] Hosp Valle De Hebron, Barcelona 08035, Spain
来源：
HAEMOPHILIA | 2002年 / 8卷 / 05期
关键词：
D O I：
10.1046/j.1365-2516.2002.00657.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：729 / 730
页数：2
相关论文
共 50 条
  • [41] Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment
    Den Uijl, I.
    Mauser-Bunschoten, E. P.
    Roosendaal, G.
    Schutgens, R.
    Fischer, K.
    HAEMOPHILIA, 2009, 15 (06) : 1215 - 1218
  • [42] Long-term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review
    O'Hara, J.
    Sima, C. S.
    Frimpter, J.
    Paliargues, F.
    Chu, P.
    Presch, I.
    HAEMOPHILIA, 2018, 24 (05) : E301 - E311
  • [43] Barriers to prophylactic treatment among patients with haemophilia A in Shandong Province, China: a qualitative study
    Liu, Ziyu
    Feng, Junchao
    Fang, Yunhai
    Cheng, Yan
    Li, Shunping
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [44] Prophylactic therapy for haemophilia: early experience - Discussion
    Giangrande, P
    Berntorp, E
    Manco-Johnson, M
    Shapiro, A
    Rodriguez-Merchan, C
    Kilcoyne, R
    Astermark, J
    Fischer, K
    HAEMOPHILIA, 2003, 9 : 9 - 9
  • [45] The influence of prophylactic factor VIII in severe haemophilia A
    Gissel, M.
    Whelihan, M. F.
    Ferris, L. A.
    Mann, K. G.
    Rivard, G. E.
    Brummel-Ziedins, K. E.
    HAEMOPHILIA, 2012, 18 (02) : 193 - 199
  • [46] On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden:: differences in treatment characteristics and outcome
    Carlsson, KS
    Höjgård, S
    Glomstein, A
    Lethagen, S
    Schulman, S
    Tengborn, L
    Lindgren, A
    Berntorp, E
    Lindgren, B
    HAEMOPHILIA, 2003, 9 (05) : 555 - 566
  • [47] Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
    Fischer, K
    Astermark, J
    Van der Bom, JG
    Ljung, R
    Berntorp, E
    Grobbee, DE
    Van den Berg, HM
    HAEMOPHILIA, 2002, 8 (06) : 753 - 760
  • [48] Experience of home prophylactic treatment of inhibitory form of haemophilia A in children using recombinant activated FVII
    Vdovin, V.
    Svirin, P.
    Shiller, E.
    Luchinkina, E.
    Malkova, O.
    Ageenkova, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1085 - 1085
  • [49] What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
    Petrini, P
    HAEMOPHILIA, 2001, 7 (01) : 99 - 102
  • [50] Assessing patient preferences and quality-adjusted life years (QALY) of prophylactic haemophilia treatment
    Schramm, B
    Berger, K
    Siebert, U
    Berntorp, E
    Giangrande, P
    van den Berg, M
    Schramm, W
    VALUE IN HEALTH, 2003, 6 (06) : 743 - 743
12345